HomeACAD • NASDAQ
ACADIA Pharmaceuticals Inc
add
$16.62
1.84%
After Hours:(0.00%)0.00
$16.62
Closed: Apr 2, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 259.60M | 12.36% |
Operating expense | 130.08M | 16.70% |
Net income | 143.74M | 213.87% |
Net profit margin | 55.37 | 179.36% |
Earnings per share | 0.86 | 207.14% |
EBITDA | 12.20M | -66.64% |
Effective tax rate | 10.77% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 755.99M | 72.26% |
Total assets | 1.19B | 58.59% |
Total liabilities | 454.96M | 43.43% |
Total equity | 732.79M | — |
Shares outstanding | 166.79M | — |
Price to book | 3.71 | — |
Return on assets | 1.61% | — |
Return on capital | 2.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 143.74M | 213.87% |
Cash from operations | 40.38M | -52.71% |
Cash from investing | 122.15M | 35,301.73% |
Cash from financing | 1.97M | -63.77% |
Net change in cash | 164.44M | 81.77% |
Free cash flow | 110.12M | 78.29% |
Previous close
$16.32
Day range
$16.18 - $16.73
Year range
$14.15 - $20.67
Market cap
2.77B USD
Avg Volume
1.69M
P/E ratio
12.21
Dividend yield
-
Primary exchange
NASDAQ
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
654
